Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMGN Amgen	$296.23 +2.0%	$281.37	$253.30 ▼ $346.85	$159.26B	0.49	2.83 million shs	686,355 shs
BIIB Biogen	$134.12 +3.1%	$126.09	$110.04 ▼ $238.00	$19.62B	0.14	1.43 million shs	298,645 shs
INCY Incyte	$68.77 +0.1%	$64.94	$53.56 ▼ $83.95	$13.29B	0.68	1.97 million shs	354,530 shs
LLY Eli Lilly and Company	$775.48 -0.1%	$778.38	$677.09 ▼ $972.53	$734.95B	0.4	3.86 million shs	558,422 shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMGN Amgen	+4.05%	+4.70%	+1.22%	-4.97%	-6.59%
BIIB Biogen	+3.57%	+2.98%	-0.79%	-0.95%	-43.88%
INCY Incyte	+0.93%	-0.41%	+5.33%	+10.27%	+12.91%
LLY Eli Lilly and Company	-0.36%	-0.31%	+5.18%	-5.25%	-15.07%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMGN Amgen	4.3129 of 5 stars	2.2	2.0	3.3	3.9	3.9	2.5	0.6
BIIB Biogen	4.9742 of 5 stars	4.2	5.0	0.0	3.7	3.9	1.7	2.5
INCY Incyte	4.3621 of 5 stars	2.1	3.0	0.0	3.1	2.5	2.5	3.1
LLY Eli Lilly and Company	4.9882 of 5 stars	4.4	4.0	3.3	4.0	2.9	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMGN Amgen	2.35	Hold	$307.82	3.91% Upside
BIIB Biogen	2.38	Hold	$188.48	40.53% Upside
INCY Incyte	2.22	Hold	$74.53	8.38% Upside
LLY Eli Lilly and Company	2.75	Moderate Buy	$1,011.61	30.45% Upside

Current Analyst Ratings Breakdown

Latest LLY, AMGN, BIIB, and INCY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/27/2025	AMGN Amgen	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$328.00
6/26/2025	BIIB Biogen	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$187.00
6/25/2025	BIIB Biogen	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$205.00 ➝ $213.00
6/24/2025	AMGN Amgen	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
6/24/2025	AMGN Amgen	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$305.00
6/23/2025	INCY Incyte	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Sector Perform ➝ Sector Perform	$67.00
6/20/2025	LLY Eli Lilly and Company	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$936.00
6/16/2025	INCY Incyte	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$75.00 ➝ $107.00
6/12/2025	BIIB Biogen	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$115.00
6/12/2025	BIIB Biogen	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$121.00
6/12/2025	BIIB Biogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMGN Amgen	$33.42B	4.77	$32.23 per share	9.19	$10.93 per share	27.10
BIIB Biogen	$9.68B	2.03	$24.70 per share	5.43	$114.71 per share	1.17
INCY Incyte	$4.24B	3.14	$0.56 per share	123.01	$17.90 per share	3.84
LLY Eli Lilly and Company	$45.04B	16.32	$14.16 per share	54.76	$15.03 per share	51.60

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMGN Amgen	$4.09B	$10.96	27.02	13.85	2.53	17.39%	176.11%	12.39%	8/5/2025 (Estimated)
BIIB Biogen	$1.63B	$10.13	13.22	8.12	1.00	15.07%	14.03%	8.32%	7/30/2025 (Estimated)
INCY Incyte	$32.62M	$0.32	214.63	10.52	0.57	0.48%	2.77%	1.77%	7/29/2025 (Estimated)
LLY Eli Lilly and Company	$10.59B	$12.29	63.10	24.92	1.14	22.67%	85.51%	15.74%	8/7/2025 (Estimated)

Latest LLY, AMGN, BIIB, and INCY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	INCY Incyte	$1.38	N/A	N/A	N/A	$1.15 billion	N/A
5/1/2025	Q1 2025	AMGN Amgen	$4.18	$4.90	+$0.72	$3.20	$8.05 billion	$8.15 billion
5/1/2025	Q1 2025	BIIB Biogen	$3.26	$3.02	-$0.24	$1.64	$2.25 billion	$2.43 billion
5/1/2025	Q1 2025	LLY Eli Lilly and Company	$4.64	$3.34	-$1.30	$3.06	$12.77 billion	$12.73 billion
4/29/2025	Q1 2025	INCY Incyte	$1.01	$1.16	+$0.15	$0.80	$996.17 million	$1.05 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMGN Amgen	$9.52	3.21%	N/A	86.86%	14 Years
BIIB Biogen	N/A	N/A	N/A	N/A	N/A
INCY Incyte	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.00	0.77%	N/A	48.82%	11 Years

Latest LLY, AMGN, BIIB, and INCY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/23/2025	LLY Eli Lilly and Company	quarterly	$1.50	0.78%	8/15/2025	8/15/2025	9/10/2025
5/5/2025	LLY Eli Lilly and Company	quarterly	$1.50	0.73%	5/16/2025	5/16/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMGN Amgen	8.70	1.17	0.88
BIIB Biogen	0.27	1.44	1.01
INCY Incyte	0.01	2.04	2.00
LLY Eli Lilly and Company	2.18	1.37	1.06

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMGN Amgen	76.50%
BIIB Biogen	87.93%
INCY Incyte	96.97%
LLY Eli Lilly and Company	82.53%

Insider Ownership

Company	Insider Ownership
AMGN Amgen	0.69%
BIIB Biogen	0.18%
INCY Incyte	17.80%
LLY Eli Lilly and Company	0.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMGN Amgen	28,000	537.71 million	534.00 million	Optionable
BIIB Biogen	7,605	146.53 million	146.26 million	Optionable
INCY Incyte	2,617	193.57 million	159.12 million	Optionable
LLY Eli Lilly and Company	47,000	947.74 million	946.41 million	Optionable

LLY, AMGN, BIIB, and INCY Headlines

Recent News About These Companies

Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?

1 hour ago | zacks.com

Sage Advisors LLC Grows Holdings in Eli Lilly and Company (NYSE:LLY)

July 2 at 5:49 AM | marketbeat.com